As of today (2024-04-16), Haemonetics's share price is $83.91. Haemonetics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-0.81. Hence, Haemonetics's Price to Tangible Book Ratio of today is .
The historical rank and industry rank for Haemonetics's Price-to-Tangible-Book or its related term are showing as below:
During the past 13 years, Haemonetics's highest Price to Tangible Book Ratio was 2102.58. The lowest was 5.34. And the median was 9.96.
HAE's Price-to-Tangible-Book is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.615 * Ranked among companies with meaningful Price-to-Tangible-Book only.
A closely related ratio is called PB Ratio. As of today, Haemonetics's share price is $83.91. Haemonetics's Book Value per Sharefor the quarter that ended in Dec. 2023 was $18.58. Hence, Haemonetics's P/B Ratio of today is 4.52.
Haemonetics Price-to-Tangible-Book Historical Data
The historical data trend for Haemonetics's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Haemonetics Annual Data
Trend
Mar14
Mar15
Mar16
Mar17
Mar18
Mar19
Mar20
Mar21
Mar22
Mar23
Price-to-Tangible-Book
13.55
20.61
-
-
54.95
Haemonetics Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Price-to-Tangible-Book
155.74
54.95
33.06
25.57
-
Competitive Comparison
For the Medical Instruments & Supplies subindustry, Haemonetics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haemonetics Price-to-Tangible-Book Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Haemonetics's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Haemonetics's Price-to-Tangible-Book falls into.
Haemonetics Price-to-Tangible-Book Calculation
Haemonetics's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Haemonetics Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Haemonetics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HAE has been successfully added to your 